Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay ...

Approximately 3.2 million Americans suffering from cancer, heart disease, and other serious or life-threatening diseases benefit from home infusion therapy. As the name suggests, home infusion therapy ...

Forbes contributors publish independent expert analyses and insights. James Broughel is an economist focused on the economics of regulation. Shortages are most damaging when they involve basic ...

U.K. pharmaceutical agreement is an important reminder that there is a smarter way to address global drug-pricing disparities ...

For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

The House of Representatives just passed a resolution condemning the “horrors of socialism” by a 285 to 98 margin. All the no votes were cast by Democrats indicating that a majority of the members ...

“We support efforts to lower the price of medicines and improve patient access, but these efforts must be grounded in market-based principles that respect free enterprise and foster future medical ...

The Colorado House has advanced a bill to bar companies from using personal data to set individualized wages and prices. As The Gazette reports, House Bill 26-1210 is a reincarnated version of a ...